ResearchMoz.us

ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Showing posts with label Shares. Show all posts
Showing posts with label Shares. Show all posts

Friday, 25 September 2015

Global Rubber Gloves Industry 2015 – Worldwide Industry Research, Analysis, Trends, Size, Shares, and Forecast

Posted on 03:24 by Unknown
The Global Rubber Gloves Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Rubber Gloves industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Rubber Gloves market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.


Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Rubber Gloves industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.


Table of Contents

1 Industry Overview

1.1 Definition and Specifications of Rubber Gloves

1.2 Classification of Rubber Gloves

1.3 Applications of Rubber Gloves

1.4 Industry Chain Structure of Rubber Gloves

1.5 Industry Regional Overview of Rubber Gloves

1.6 Industry Policy Analysis of Rubber Gloves

1.7 Industry News Analysis of Rubber Gloves

2 Manufacturing Cost Structure Analysis of Rubber Gloves

2.1 Raw Material Suppliers and Price Analysis of Rubber Gloves

2.2 Equipment Suppliers and Price Analysis of Rubber Gloves

2.3 Labor Cost Analysis of Rubber Gloves

2.4 Other Costs Analysis of Rubber Gloves

2.5 Manufacturing Cost Structure Analysis of Rubber Gloves

2.6 Manufacturing Process Analysis of Rubber Gloves

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014

3.2 Manufacturing Plants Distribution of Global Key Rubber Gloves Manufacturers in 2014

3.3 R&D Status and Technology Source of Global Rubber Gloves Key Manufacturers in 2014

3.4 Raw Materials Sources Analysis of Global Rubber Gloves Key Manufacturers in 2014


For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , | No comments

Friday, 18 September 2015

Global Herbal Supplements and Remedies Industry 2015 : Global Industry Growth, Research, Analysis, Shares and Forecast

Posted on 00:43 by Unknown
The Global Herbal Supplements and Remedies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Herbal Supplements and Remedies industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Herbal Supplements and Remedies market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.


The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Herbal Supplements and Remedies industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 240 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Herbal Supplements and Remedies
1.2 Classification of Herbal Supplements and Remedies
1.3 Applications of Herbal Supplements and Remedies
1.4 Industry Chain Structure of Herbal Supplements and Remedies
1.5 Industry Regional Overview of Herbal Supplements and Remedies
1.6 Industry Policy Analysis of Herbal Supplements and Remedies
1.7 Industry News Analysis of Herbal Supplements and Remedies

2 Manufacturing Cost Structure Analysis of Herbal Supplements and Remedies
2.1 Raw Material Suppliers and Price Analysis of Herbal Supplements and Remedies
2.2 Equipment Suppliers and Price Analysis of Herbal Supplements and Remedies
2.3 Labor Cost Analysis of Herbal Supplements and Remedies
2.4 Other Costs Analysis of Herbal Supplements and Remedies
2.5 Manufacturing Cost Structure Analysis of Herbal Supplements and Remedies
2.6 Manufacturing Process Analysis of Herbal Supplements and Remedies

All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Herbal Supplements and Remedies Manufacturers in 2014
3.3 R&D Status and Technology Source of Global Herbal Supplements and Remedies Key Manufacturers in 2014

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , | No comments

Tuesday, 15 September 2015

Global Cancer Biomarkers Industry 2015 - Worldwide Market Size, Shares, Trends, Growth, Survey, Outlook and Overview Report

Posted on 00:49 by Unknown
The Global Cancer Biomarkers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Cancer Biomarkers industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Cancer Biomarkers market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.


The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Cancer Biomarkers industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 285 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Cancer Biomarkers
1.2 Classification of Cancer Biomarkers
1.3 Applications of Cancer Biomarkers
1.4 Industry Chain Structure of Cancer Biomarkers
1.5 Industry Regional Overview of Cancer Biomarkers
1.6 Industry Policy Analysis of Cancer Biomarkers
1.7 Industry News Analysis of Cancer Biomarkers

2 Manufacturing Cost Structure Analysis of Cancer Biomarkers
2.1 Raw Material Suppliers and Price Analysis of Cancer Biomarkers
2.2 Equipment Suppliers and Price Analysis of Cancer Biomarkers
2.3 Labor Cost Analysis of Cancer Biomarkers
2.4 Other Costs Analysis of Cancer Biomarkers
2.5 Manufacturing Cost Structure Analysis of Cancer Biomarkers
2.6 Manufacturing Process Analysis of Cancer Biomarkers

All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Cancer Biomarkers Manufacturers in 2014
3.3 R&D Status and Technology Source of Global Cancer Biomarkers Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Cancer Biomarkers Key Manufacturers in 2014

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , | No comments

Monday, 7 September 2015

Europe Atomic Spectroscopy Industry 2015 Market Research Report : Global Industry Growth, Research, Analysis, Shares and Forecast

Posted on 03:04 by Unknown
The Europe Atomic Spectroscopy Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Atomic Spectroscopy industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Atomic Spectroscopy market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.


The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Atomic Spectroscopy industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 168 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Atomic Spectroscopy
1.2 Classification of Atomic Spectroscopy
1.3 Applications of Atomic Spectroscopy
1.4 Industry Chain Structure of Atomic Spectroscopy
1.5 Industry Overview of Atomic Spectroscopy
1.6 Industry Policy Analysis of Atomic Spectroscopy
1.7 Industry News Analysis of Atomic Spectroscopy

Chapter Two Manufacturing Cost Structure Analysis of Atomic Spectroscopy
2.1 Bill of Materials (BOM) of Atomic Spectroscopy
2.2 BOM Price Analysis of Atomic Spectroscopy
2.3 Labor Cost Analysis of Atomic Spectroscopy
2.4 Depreciation Cost Analysis of Atomic Spectroscopy
2.5 Manufacturing Cost Structure Analysis of Atomic Spectroscopy
2.6 Manufacturing Process Analysis of Atomic Spectroscopy


Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Europe Key Atomic Spectroscopy Manufacturers in 2014
3.3 R&D Status and Technology Source of Europe Atomic Spectroscopy Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Europe Atomic Spectroscopy Key Manufacturers in 2014

Chapter Four Production Analysis of Atomic Spectroscopy by Regions, Technology, and Applications
4.1 Europe Production of Atomic Spectroscopy by Regions (Key Provinces) 2010-2015
4.2 Europe Production of Atomic Spectroscopy by Product Types 2010-2015
4.3 Europe Sales of Atomic Spectroscopy by Applications 2010-2015
4.4 Price Analysis of Europe Atomic Spectroscopy Key Manufacturers in 2015
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Atomic Spectroscopy 2010-2015

Chapter Five Sales and Revenue Analysis of Atomic Spectroscopy by Regions
5.1 Europe Sales of Atomic Spectroscopy by Regions 2010-2015
5.2 Europe Revenue of Atomic Spectroscopy by Regions 2010-2015
5.3 Europe Price Analysis of Atomic Spectroscopy Sales by Regions 2010-2015
5.4 Europe Price, Cost and Gross of Atomic Spectroscopy 2010-2015

All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Chapter Six Analysis of Atomic Spectroscopy Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Atomic Spectroscopy 2010-2015
6.2 Production Sales Market Share Analysis of Atomic Spectroscopy 2014-2015
6.3 Import, Export and Consumption of Atomic Spectroscopy 2010-2015
6.4 Supply, Consumption and Shortage of Atomic Spectroscopy 2010-2015
6.5 Import, Export and Consumption of Atomic Spectroscopy 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Atomic Spectroscopy 2010-2015

Chapter Seven Analysis of Atomic Spectroscopy Industry Key Manufacturers
7.1 Bruker Corporation
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Bruker Corporation SWOT Analysis




For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , | No comments

Wednesday, 2 September 2015

Recurrent Malignant Glioma - Pipeline Review, H2 2015 : Global Industry Growth, Research, Analysis, Shares and Forecast

Posted on 01:03 by Unknown
Product Synopsis

Recurrent Malignant Glioma - Pipeline Review, H2 2015

Summary

Global Markets Directs, Recurrent Malignant Glioma - Pipeline Review, H2 2015, provides an overview of the Recurrent Malignant Gliomas therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Recurrent Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Malignant Glioma and special features on late-stage and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Recurrent Malignant Glioma
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Recurrent Malignant Glioma and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Recurrent Malignant Glioma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Recurrent Malignant Glioma pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products


Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Recurrent Malignant Glioma
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Recurrent Malignant Glioma pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , | No comments

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015 : Global Industry Growth, Research, Analysis, Shares and Forecast

Posted on 00:59 by Unknown
Product Synopsis

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015

Summary

Global Markets Directs, Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015, provides an overview of the Elephantiasis (Lymphatic Filariasis)s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Elephantiasis (Lymphatic Filariasis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Elephantiasis (Lymphatic Filariasis) and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Elephantiasis (Lymphatic Filariasis)
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Elephantiasis (Lymphatic Filariasis) and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Elephantiasis (Lymphatic Filariasis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Elephantiasis (Lymphatic Filariasis) pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products


Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Elephantiasis (Lymphatic Filariasis)
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Elephantiasis (Lymphatic Filariasis) pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , | No comments

Vaccinex, Inc. - Product Pipeline Review - 2015: Global Industry Growth, Research, Analysis, Shares and Forecast

Posted on 00:37 by Unknown
Product Synopsis

Vaccinex, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Directs, Vaccinex, Inc. - Product Pipeline Review - 2015, provides an overview of the Vaccinex, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vaccinex, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Vaccinex, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vaccinex, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Vaccinex, Inc.s pipeline products


Reasons to buy

- Evaluate Vaccinex, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vaccinex, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vaccinex, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vaccinex, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vaccinex, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Vaccinex, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , , | No comments

Marina Biotech, Inc. - Product Pipeline Review - 2015: Global Industry Growth, Research, Analysis, Shares and Forecast

Posted on 00:07 by Unknown
Product Synopsis

Marina Biotech, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Directs, Marina Biotech, Inc. - Product Pipeline Review - 2015, provides an overview of the Marina Biotech, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Marina Biotech, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Marina Biotech, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Marina Biotech, Inc.s human therapeutic division and enlists all their major and minor projects



- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Marina Biotech, Inc.s pipeline products

Reasons to buy

- Evaluate Marina Biotech, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Marina Biotech, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Marina Biotech, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Marina Biotech, Inc. and exploit collaboration and partnership opportunities


For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Marina Biotech, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Marina Biotech, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , | No comments

Monday, 31 August 2015

United States Propolis Industry 2015 – Worldwide Industry Research, Analysis, Trends, Size, Shares

Posted on 02:25 by Unknown
The United States Propolis Industry Report 2015 is a professional and in-depth study on the current state of the Propolis industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Propolis market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.


The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Propolis industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.


Table of Content:-

Chapter One Industry Overview

1.1 Definition and Specifications of Propolis

1.2 Classification of Propolis

1.3 Applications of Propolis

1.4 Industry Chain Structure of Propolis

1.5 Industry Overview of Propolis

1.6 Industry Policy Analysis of Propolis

1.7 Industry News Analysis of Propolis

Chapter Two Manufacturing Cost Structure Analysis of Propolis

2.1 Bill of Materials(BOM) of Propolis

2.2 BOM Price Analysis of Propolis

2.3 Labor Cost Analysis of Propolis

2.4 Depreciation Cost Analysis of Propolis

2.5 Manufacturing Cost Structure Analysis of Propolis

2.6 Manufacturing Process Analysis of Propolis

Chapter Three Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014

3.2 Manufacturing Plants Distribution of United States Key Propolis Manufacturers in 2014

3.3 R&D Status and Technology Source of United States Propolis Key Manufacturers in 2014

3.4 Raw Materials Sources Analysis of United States Propolis Key Manufacturers in 2014

Chapter Four Production Analysis of Propolis by Regions, Technology, and Applications

4.1 United States Production of Propolis by Regions (Key Provinces) 2010–2015

4.2 United States Production of Propolis by Product Type 2010–2015

4.3 United States Sales of Propolis by Applications 2010–2015

4.4 Price Analysis of United States Propolis Key Manufacturers in 2015

4.5 United States Capacity, Production, Price, Cost and Revenue of Propolis 2010–2015

4.6 United States Supply, Import, Export and Consumption of Propolis 2010–2015

Chapter Five Sales and Revenue Analysis of Propolis by Regions

5.1 United States Sales of Propolis by Regions 2010–2015

5.2 United States Revenue of Propolis by Regions 2010–2015

5.3 United States Price Analysis of Propolis Sales by Regions 2010–2015

5.4 United States Price, Cost and Gross of Propolis 2010–2015



For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted in , , , , | No comments

Tuesday, 26 May 2015

Global Menswear Industry Analysis, Shares, Size, Trends, Growth and Research Report

Posted on 06:00 by Unknown
ResearchMoz.us includes new market research report " Global Menswear Industry Guide: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports. 

Global Menswear industry guide provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. 




Features and benefits:- 
Save time carrying out entry-level research by identifying the size, growth, and leading players in the global menswear market 
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global menswear market 
Leading company profiles reveal details of key menswear market players’ global operations and financial performance 
Add weight to presentations and pitches by understanding the future growth prospects of the global menswear market with five year forecasts 

Sample of Table of Content:- 


EXECUTIVE SUMMARY 

Market value 

Market value forecast 

Geography segmentation 


INTRODUCTION 

What is this report about? 

Who is the target reader? 

How to use this report 


Definitions 

GLOBAL MENSWEAR 

Market Overview 

Market Data 

Market Segmentation 

Market outlook 

Five forces analysis





Highlights:- 
The global menswear market had total revenues of $438.0bn in 2014, representing a compound annual growth rate (CAGR) of 4.6% between 2010 and 2014. 
Clothing, Footwear, Sportswear & Accessories Retailers account for the largest proportion of sales in the global menswear market in 2014. Sales through this channel generated $235.3bn, equivalent to 53.7% of the market's overall value. 
The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.8% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $553.6bn by the end of 2019. 


Posted in , , | No comments
Subscribe to: Posts (Atom)